Rasmus Sejersten Ripa

Rasmus Sejersten Ripa serves as Clinical Professor at the Department of Clinical Medicine and Professor/Senior Consultant at the Department of Biomedical Sciences within the Cluster for Molecular Imaging at the University of Copenhagen's Faculty of Health and Medical Sciences. He concurrently works as Chief Physician at Bispebjerg Hospital's Department of Clinical Physiology and Nuclear Medicine since 2024 and maintains an active clinical role as Senior Consultant at Copenhagen University Hospital - Bispebjerg and Frederiksberg.

His primary research focuses on developing and applying positron emission tomography (PET) imaging techniques for cardiovascular diseases, with particular emphasis on molecular imaging of atherosclerosis, vascular inflammation, and cardiac complications in diabetes. His work bridges clinical practice with advanced imaging technology development.

Analysis of his recent publications (including multiple 2025 papers) reveals a strong research trajectory in using PET/MRI for assessing arterial inflammation in diabetes, novel radiotracers for cardiovascular imaging, and understanding microcirculatory dysfunction. His work increasingly integrates diabetes management with cardiovascular imaging, particularly examining how diabetes medications affect vascular inflammation.

Ripa has served as Editor for BMC Cardiovascular Disorders (2011-2015) and guest editor for a Special Issue on 'Positron Emission Tomography (PET) in Cardiovascular Disease' in Diagnostics journal (2013), demonstrating his leadership in the field. His research has attracted industry support through travel grants from GE Healthcare and Siemens Healthineers, with consultancy relationships with Minerva Imaging and Novo Nordisk A/S.

He leads research activities within the Cluster for Molecular Imaging, focusing on translating molecular imaging techniques from bench to bedside for cardiovascular applications. His work involves close collaboration between the University of Copenhagen and Copenhagen University Hospitals, creating an integrated research-clinical environment for advancing cardiovascular imaging.